Biogen Inc. buy BMO Capital Markets
Start price
08.08.23
/
50%
€249.40
Target price
08.08.24
€306.84
Performance (%)
-25.40%
End price
09.08.24
€186.05
Summary
This prediction ended on 09.08.24 with a price of €186.05. The prediction for Biogen Inc. disappointed with a performance of -25.40%. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | |
|---|---|---|---|---|
| Biogen Inc. | 2.181% | 2.181% | 64.049% | |
| iShares Core DAX® | 2,57 % | 3,50 % | 8,41 % | - |
| iShares Nasdaq 100 | 4,86 % | 0,65 % | 28,38 % | - |
| iShares Nikkei 225® | 5,59 % | -0,25 % | 52,92 % | - |
| iShares S&P 500 | 3,25 % | 2,08 % | 24,37 % | - |
Comments by BMO_Capital_Markets for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) had its price target lowered by analysts at BMO Capital Markets from $347.00 to $336.00. They now have an "outperform" rating on the stock.
Ratings data for BIIB provided by MarketBeat
In the thread Trading Biogen Inc.
Die von BMO_Capital_Markets gewählte maximale Laufzeit wurde überschritten